MedPath

Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: Antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin
Behavioral: Diabetes survival skills self-management education
Registration Number
NCT01033773
Lead Sponsor
Medstar Health Research Institute
Brief Summary

To demonstrate that a focused Emergency Department (ED) intervention for uncontrolled hyperglycemia enables safe and effective glycemic management and reduces emergency room re-visits. We assessed hypoglycemia BG \< 60mg/dL; change in mean blood glucose and A1C, and ED revisits for hyperglycemia.

Detailed Description

Patients with BG \> 200mg/dL presenting to an urban tertiary care hospital ED were enrolled in a 4 week prospective intervention with historic self-controls. Subjects returned at 12-72 hours, 2 and 4 weeks. Diabetes medications (including sulfonylureas, metformin and/or insulin) were initiated and/or adjusted at each visit using the intervention algorithm per presenting blood glucose and prior diabetes medications. Survival skills self-management education and navigation to outpatient services were provided.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
86
Inclusion Criteria
  • Age > 18 years
  • Type 2 Diabetes Mellitus,
  • random BG > 200 mg/dL,
  • willing and able to provide informed consent and to participate in diabetes self-management education (DSME)
  • stable for discharge from the ED once hyperglycemia treatment initiated.
Exclusion Criteria
  • type 1 Diabetes Mellitus,
  • diabetic ketoacidosis or hyperosmolar non-ketotic state,
  • concomitant treatment with glucocorticoids (other than stable maintenance dose therapy),
  • cognitive or physical impairment preventing participation in DSME
  • unwillingness or inability to provide consent and/or attend follow-up visits.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Diabetes education and medication managementDiabetes survival skills self-management educationAll enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post.
Diabetes education and medication managementAntihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulinAll enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post.
Primary Outcome Measures
NameTimeMethod
Total Number of Hypoglycemia Events (Blood Glucose < 60mg/dL) Within 24 Hours of Baseline Visit24 hours

Total Number of hypoglycemic events defined as Blood Glucose \< 60 within 24 hours of index emergency room visit (baseline)

Secondary Outcome Measures
NameTimeMethod
Change in Hemoglobin A1C From Baseline to End of Intervention at 30 Days30 days

difference between mean hemoglobin A1C at baseline and mean Hemoglobin A1C to end of intervention

Change in Mean Blood Glucose From Time of Presentation to Emergency Room to End of Intervention 30 Days From Baseline30 days

Mean difference in of blood glucose in mg/dl between baseline mean BG and end of intervention mean BG 30 days from baseline

Trial Locations

Locations (1)

Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath